NL-OMON45144已完成不适用
Identification of muscle-invasive bladder cancer patients who will not benefit from neoadjuvant chemotherapy using circulating tumor cells. - CTCs to guide neoadjuvant chemotherapy in bladder cancer.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 320
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Histopathologically confirmed muscle-invasive urothelial carcinoma of the bladder.
- •- Clinical stage T2-T4a N0-N1 bladder cancer.
- •- Candidate for radical local treatment consisting of radical cystectomy.
- •- Age * 18 years.
- •- Signed informed consent
排除标准
- •- Muscle-invasive bladder cancer other than urothelial carcinoma (adenocarcinoma, squamous cell carcinoma, small cell carcinoma, neuro-endocrine tumor).
- •- History of other malignant disease with a tumor-free interval of * 5 years.
- •- Known or suspected coincidental prostate cancer.
- •- Metastatic disease at staging, as assessed by a CT-scan of thorax and abdomen
- •- Local or systemic adjuvant treatment after radical cystectomy.
研究者
相似试验
招募中
不适用
Identification of muscle-invasive bladder cancer patients who will not benefit from neoadjuvant chemotherapy using circulating tumor cells.NL-OMON23413Erasmus MC260
进行中（未招募）
不适用
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-001819-30-DESanochemia Pharmazeutika AG220
进行中（未招募）
不适用
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-001819-30-ATSanochemia Pharmazeutika AG220
已完成
2 期
Detection of non-muscle invasive bladder cancer using PVP-Hypericin (Vidon®) fluorescence cystoscopy(Hypericin PDD)C67Malignant neoplasm of bladderDRKS00003324Sanochemia Pharmazeutika AG227
已完成
3 期
The IMAGE1 S* Non-Muscle-Invasive bladder cancer study: A multicenter international randomized controlled study to compare the outcome using the IMAGE1 S* System versus White Light Imaging (WLI) during TURB of Non-Muscle-Invasive Bladder Cancer (NMIBC).bladder cancerNL-OMON47283Academisch Medisch Centrum100